Re:NewCell Past Earnings Performance
Past criteria checks 0/6
Re:NewCell's earnings have been declining at an average annual rate of -52.6%, while the Chemicals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 95.5% per year.
Key information
-52.6%
Earnings growth rate
-36.4%
EPS growth rate
| Chemicals Industry Growth | 32.9% |
| Revenue growth rate | 95.5% |
| Return on equity | -50.3% |
| Net Margin | -195.6% |
| Next Earnings Update | 26 Apr 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Re:NewCell makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 205 | -401 | 199 | 0 |
| 30 Jun 23 | 124 | -408 | 203 | 0 |
| 31 Mar 23 | 41 | -371 | 201 | 0 |
| 31 Dec 22 | 14 | -300 | 185 | 0 |
| 30 Sep 22 | 9 | -290 | 190 | 0 |
| 30 Jun 22 | 6 | -213 | 159 | 0 |
| 31 Mar 22 | 4 | -168 | 130 | 0 |
| 31 Dec 21 | 4 | -133 | 103 | 0 |
| 30 Sep 21 | 2 | -88 | 77 | 0 |
| 30 Jun 21 | 1 | -80 | 68 | 0 |
| 31 Mar 21 | 2 | -72 | 61 | 0 |
| 31 Dec 20 | 1 | -69 | 57 | 0 |
| 30 Sep 20 | 2 | -60 | 46 | 0 |
| 31 Dec 19 | 1 | -38 | 32 | 0 |
| 31 Dec 18 | 0 | -18 | 22 | 0 |
Quality Earnings: RENEW is currently unprofitable.
Growing Profit Margin: RENEW is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RENEW is unprofitable, and losses have increased over the past 5 years at a rate of 52.6% per year.
Accelerating Growth: Unable to compare RENEW's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RENEW is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-17.8%).
Return on Equity
High ROE: RENEW has a negative Return on Equity (-50.32%), as it is currently unprofitable.